Jay Grossman

4.6k total citations
75 papers, 3.4k citations indexed

About

Jay Grossman is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology and Allergy. According to data from OpenAlex, Jay Grossman has authored 75 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Physiology, 36 papers in Pulmonary and Respiratory Medicine and 27 papers in Immunology and Allergy. Recurrent topics in Jay Grossman's work include Asthma and respiratory diseases (44 papers), Allergic Rhinitis and Sensitization (27 papers) and Respiratory and Cough-Related Research (25 papers). Jay Grossman is often cited by papers focused on Asthma and respiratory diseases (44 papers), Allergic Rhinitis and Sensitization (27 papers) and Respiratory and Cough-Related Research (25 papers). Jay Grossman collaborates with scholars based in United States, Belgium and United Kingdom. Jay Grossman's co-authors include Michael Y. Wang, David S. Pearlman, Edwin A. Bronsky, Robert J. Dockhorn, Peng-Yuan Chang, James P. Kemp, Paul H. Ratner, Andre van As, Eli O. Meltzer and Steven R. Findlay and has published in prestigious journals such as New England Journal of Medicine, Annals of Internal Medicine and Neurology.

In The Last Decade

Jay Grossman

70 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jay Grossman United States 32 2.2k 1.5k 1.4k 599 325 75 3.4k
Giovanni Rolla Italy 38 2.1k 1.0× 1.8k 1.2× 741 0.5× 728 1.2× 246 0.8× 183 4.2k
Murugappan Ramanathan United States 31 969 0.5× 812 0.5× 919 0.7× 492 0.8× 39 0.1× 130 2.9k
Gabriele Di Lorenzo Italy 33 1.3k 0.6× 438 0.3× 1.2k 0.9× 266 0.4× 298 0.9× 125 3.5k
Hisako Matsumoto Japan 39 2.9k 1.3× 3.3k 2.2× 441 0.3× 667 1.1× 75 0.2× 195 5.0k
Fuad M. Baroody United States 39 2.7k 1.2× 1.1k 0.7× 2.5k 1.8× 1.0k 1.7× 49 0.2× 179 4.6k
Albert L. Sheffer United States 37 1.3k 0.6× 611 0.4× 1.5k 1.1× 366 0.6× 523 1.6× 113 4.3k
J.V. Collins United Kingdom 23 2.3k 1.1× 1.8k 1.2× 594 0.4× 415 0.7× 109 0.3× 51 3.5k
H. J. Sluiter Netherlands 27 2.2k 1.0× 2.1k 1.4× 601 0.4× 236 0.4× 50 0.2× 67 3.5k
Kevin C. Welch United States 29 1.2k 0.6× 408 0.3× 988 0.7× 1.1k 1.9× 59 0.2× 108 3.0k
V J Lund United Kingdom 26 1.4k 0.6× 607 0.4× 1.7k 1.2× 1.9k 3.1× 36 0.1× 55 4.1k

Countries citing papers authored by Jay Grossman

Since Specialization
Citations

This map shows the geographic impact of Jay Grossman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay Grossman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay Grossman more than expected).

Fields of papers citing papers by Jay Grossman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jay Grossman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay Grossman. The network helps show where Jay Grossman may publish in the future.

Co-authorship network of co-authors of Jay Grossman

This figure shows the co-authorship network connecting the top 25 collaborators of Jay Grossman. A scholar is included among the top collaborators of Jay Grossman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jay Grossman. Jay Grossman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Michael Y. & Jay Grossman. (2025). Awake, endoscopic lumbar interbody spinal fusion: 10 years of experience with the first 400 cases. Journal of Neurosurgery Spine. 42(4). 435–442.
2.
Grossman, Jay, et al.. (2007). Long-term experience with the use of fibrin sealant in aesthetic surgery. Aesthetic Surgery Journal. 27(5). 558–562. 16 indexed citations
3.
Bronsky, Edwin A., Jay Grossman, Paul Gallo, et al.. (2004). Inspiratory flow rates and volumes with the Aerolizer dry powder inhaler in asthmatic children and adults. Current Medical Research and Opinion. 20(2). 131–137. 32 indexed citations
4.
Stevens, David A., Howard J. Schwartz, Jeannette Y. Lee, et al.. (2000). A Randomized Trial of Itraconazole in Allergic Bronchopulmonary Aspergillosis. New England Journal of Medicine. 342(11). 756–762. 354 indexed citations
5.
Geoffroy, Pierre A., Richard L. Lalonde, Richard C. Ahrens, et al.. (1999). Clinical comparability of albuterol delivered by the breath-actuated inhaler (Spiros) and albuterol by MDI in patients with asthma. Annals of Allergy Asthma & Immunology. 82(4). 377–382. 15 indexed citations
6.
Grossman, Jay, et al.. (1999). Long-term safety and efficacy of zafirlukast in the treatment of asthma: interim results of an open-label extension trial. Annals of Allergy Asthma & Immunology. 82(4). 361–369. 12 indexed citations
7.
Dockhorn, Robert J., Donald W. Aaronson, Paul Chervinsky, et al.. (1999). Ipratropium bromide nasal spray 0.03% and beclomethasone nasal spray alone and in combination for the treatment of rhinorrhea in perennial rhinitis. Annals of Allergy Asthma & Immunology. 82(4). 349–359. 43 indexed citations
8.
Nathan, Robert A., Jacob L. Pinnas, Howard J. Schwartz, et al.. (1999). A six-month, placebo-controlled comparison of the safety and efficacy of salmeterol or beclomethasone for persistent asthma. Annals of Allergy Asthma & Immunology. 82(6). 521–529. 39 indexed citations
9.
DuBuske, L., Jay Grossman, Louise M. Dubé, Linda J. Swanson, & John F. Lancaster. (1997). Randomized trial of zileuton in patients with moderate asthma: effect of reduced dosing frequency and amounts on pulmonary function and asthma symptoms. Zileuton Study Group.. PubMed. 3(4). 633–40. 18 indexed citations
10.
DuBuske, L., et al.. (1997). Randomized Trial of Zileuton in Patients with Moderate Asthma: Effect of Reduced Dosing Frequency and Amounts on Pulmonary Function and Asthma Symptoms. The American Journal of Managed Care. 3. 15 indexed citations
11.
Middleton, Elliott, William W. Storms, Robert J. Dockhorn, et al.. (1996). Corticosteroid-Sparing Effect of Azelastine in the Management of Bronchial Asthma. American Journal of Respiratory and Critical Care Medicine. 153(1). 122–127. 36 indexed citations
12.
Lockey, Richard F., et al.. (1996). Comparative Study of Cetirizine and Terfenadine Versus Placebo in the Symptomatic Management of Seasonal Allergic Rhinitis. Annals of Allergy Asthma & Immunology. 76(5). 448–454. 41 indexed citations
13.
Grossman, Jay. (1994). The Evolution of Inhaler Technology. Journal of Asthma. 31(1). 55–64. 50 indexed citations
14.
Pearlman, David S., Paul Chervinsky, Craig LaForce, et al.. (1992). A Comparison of Salmeterol with Albuterol in the Treatment of Mild-to-Moderate Asthma. New England Journal of Medicine. 327(20). 1420–1425. 290 indexed citations
15.
Meltzer, Eli O., H.Alice Orgel, Edwin A. Bronsky, et al.. (1992). Ipratropium bromide aqueous nasal spray for patients with perennial allergic rhinitis: A study of its effect on their symptoms, quality of life, and nasal cytology. Journal of Allergy and Clinical Immunology. 90(2). 242–249. 56 indexed citations
16.
As, Andre van, et al.. (1991). Dose tolerance study of fluticasone propionate aqueous nasal spray in patients with seasonal allergic rhinitis.. PubMed. 67(2 Pt 1). 156–62. 48 indexed citations
17.
Fireman, Philip, et al.. (1991). Once daily fluticasone propionate aqueous nasal spray is an effective treatment for seasonal allergic rhinitis.. PubMed. 67(3). 332–8. 79 indexed citations
18.
Kemp, James P., Edwin A. Bronsky, Jay Grossman, et al.. (1989). Albuterol treatment for children with asthma: A comparison of inhaled powder and aerosol. Journal of Allergy and Clinical Immunology. 83(3). 697–702. 28 indexed citations
19.
Rachelefsky, Gary S., Jay Grossman, Albert S. Rohr, et al.. (1988). Ultraslow Release Theophylline in the Pediatric Patient. Pediatric Asthma Allergy & Immunology. 2(2). 109–115.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giovanni Rolla Breakdown of academic impact, for papers by Murugappan Ramanathan Breakdown of academic impact, for papers by Gabriele Di Lorenzo Breakdown of academic impact, for papers by Hisako Matsumoto Breakdown of academic impact, for papers by Fuad M. Baroody Breakdown of academic impact, for papers by Albert L. Sheffer Breakdown of academic impact, for papers by J.V. Collins Breakdown of academic impact, for papers by H. J. Sluiter Breakdown of academic impact, for papers by Kevin C. Welch Breakdown of academic impact, for papers by V J Lund
Rankless by CCL
2026